Find Therapeutics secured CA$10 million in funding to continue advancing tasronetide, its treatment to restore damaged myelin ...

Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy alone in pre- and postmenopausal women with breast cancer.

Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...

Annual out-of-pocket costs for multiple sclerosis (MS) care in the US increased by 125% from 2002 to 2021, primarily driven by newer disease-modifying therapies (DMTs), a new study showed. Researchers ...

A long-awaited change in drug policy could bring scientists one step closer to understanding the harms and benefits of marijuana, the most commonly used federally illegal substance. On Thursday, ...

The University of Michigan has long been a global leader in research and discovery. Today, we stand on the threshold of a new era — one defined by unprecedented possibilities in medicine, engineering, ...

For more than a century, people have considered Alzheimer's disease (AD) an irreversible illness. Consequently, research has focused on preventing or slowing it, rather than recovery. Despite billions ...

STARKVILLE, Miss.—Mississippi State University’s College of Veterinary Medicine is announcing a new partnership with Loop Abroad to expand global learning opportunities for undergraduate students ...

Learn how pyrolysis–GC/MS delivers molecular-level insight for precise polymer characterization. Understand how low sample-prep variability improves data quality and reproducibility. Explore how ...